Drug Profile
Research programme: osteoporosis therapy - Camurus AB
Alternative Names: CAM-2015; cam2015Latest Information Update: 14 Jan 2014
Price :
$50
*
At a glance
- Originator Camurus
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Osteoporosis
Most Recent Events
- 14 Jan 2014 Discontinued - Preclinical for Osteoporosis in Sweden (SC)
- 08 May 2006 This programme is still in active development
- 24 Aug 2005 Preclinical trials in Osteoporosis in Sweden (SC)